The Patent Finder

Imara, Inc.

Also on record
Records under this name other than patents Imara, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 8 of 8 · Back to Imara, Inc.

PatentTitleStatus Expires Confidence
US 11,370,795PROCESS FOR THE SYNTHESIS OF 6-[(3S,4S)-4-Methyl-1-(PYRIMIDIN-2-Ylmethyl)PYRROLIDIN-3-YL]-3-Tetrahydropyran-4-YL-7H-IMIDAZO[1,5-a]PYRAZIN-8-ONE
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,999,741PROCESS FOR THE SYNTHESIS OF 6-((3S,4S)-4-Methyl-1-(PYRIMIDIN-2-Ylmethyl)PYRROLIDIN-3-YL)-3-(TETRAHYDROPYRAN-4-YL-7H-IMIDAZO[1,5-a]PYRAZIN-8-ONE
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,466,832Monohydrate and Crystalline Forms of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 12,213,975PDE9 Inhibitors for Treating Sickle Cell Disease
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 12,006,319Monohydrate and Crystalline Forms of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 8,142,928Systems and methods for rechargeable battery collector tab configurations and foil thickness
Formerly held
Lapsed on the fee record
Ended Mar 27, 2024 · From the USPTO record
Lapsed on the fee recordEnded Mar 27, 2024From the USPTO record
US 10,537,541Treatment of Focal Segmental Glomerular Sclerosis (FSGS) Using Therapeutically Effective Oral Doses of 10-Nitro-9(E)-OCTADEC-9-Enoic Acid
Lapsed on the fee record
Ended Jan 21, 2024 · High confidence
Lapsed on the fee recordEnded Jan 21, 2024High confidence
US 9,099,738Lithium secondary batteries with positive electrode compositions and their methods of manufacturing
Lapsed on the fee record
Ended Aug 4, 2023 · From the USPTO record
Lapsed on the fee recordEnded Aug 4, 2023From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited